EMERGENCE-BIO - Emergence et maturation de projets de biotechnologie et de Technologie pour la santé à fort potentiel de valorisation

Thérapie antithrombotique basée sur l'utilisation d'anticorps monoclonaux ciblant le facteur Willebrand – ThrombAWill

Project coordinator

Cécile DENIS (Organisme de recherche)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

Help of the ANR 136,614 euros
Beginning and duration of the scientific project: - 24 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter